Abingdon Health (Abingdon Health) Debt-to-Equity : 0.56 (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Abingdon Health Debt-to-Equity?

Abingdon Health's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $0.12 Mil. Abingdon Health's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $1.15 Mil. Abingdon Health's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $2.30 Mil. Abingdon Health's debt to equity for the quarter that ended in Dec. 2023 was 0.56.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Abingdon Health's Debt-to-Equity or its related term are showing as below:

ABDXF' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.05 Med: 0.2 Max: 1.73
Current: 0.56

During the past 6 years, the highest Debt-to-Equity Ratio of Abingdon Health was 1.73. The lowest was 0.05. And the median was 0.20.

ABDXF's Debt-to-Equity is ranked worse than
69.95% of 193 companies
in the Medical Diagnostics & Research industry
Industry Median: 0.23 vs ABDXF: 0.56

Abingdon Health Debt-to-Equity Historical Data

The historical data trend for Abingdon Health's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abingdon Health Debt-to-Equity Chart

Abingdon Health Annual Data

Trend

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Debt-to-Equity

Get a 7-Day Free Trial

0.08

1.73

0.07

0.20

0.34

Abingdon Health Semi-Annual Data
	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Debt-to-Equity	Get a 7-Day Free Trial					0.06	0.20	0.27	0.34	0.56

Competitive Comparison of Abingdon Health's Debt-to-Equity

For the Diagnostics & Research subindustry, Abingdon Health's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Abingdon Health's Debt-to-Equity Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Abingdon Health's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Abingdon Health's Debt-to-Equity falls into.

Abingdon Health Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Abingdon Health's Debt to Equity Ratio for the fiscal year that ended in Jun. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.11	+	1.177)	/	3.799
	=	0.34

Abingdon Health's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.123	+	1.153)	/	2.296
	=	0.56

Abingdon Health (OTCPK:ABDXF) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Abingdon Health Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Abingdon Health's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Abingdon Health (Abingdon Health) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Abingdon Health PLC (OTCPK:ABDXF) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

ABDX:UK

Address

York Biotech Campus, Sand Hutton, York, GBR, YO41 1LZ

Website

https://www.abingdonhealth.com

Abingdon Health PLC is a technology-enabled lateral flow diagnostics company. It provides rapid testing solutions to clients in healthcare and other industries. The firm's product ABC-19 is an antibody test for Covid-19 , and also produces tests covering areas such as self-test HIV, equine infection, human fertility, etc. Business operating segments includes; Contract Development comprises development work for third parties. Contract Manufacturing comprises contract development and manufacturing activities. Product Sales comprises the sale of ABC-19, Pocket Diagnostic products, PCRD tests and antibodies for research use. Key revenue comes from Contract Development segment. Geographically it operates and earns revenue from the UK, USA and Canada, Europe and the rest of the world.

Abingdon Health (Abingdon Health) Headlines

From GuruFocus

AbC-19� Rapid Test Available for Purchase by Healthcare Professionals

By Business Wire Business Wire • 02-16-2021